Literature DB >> 25913481

Apolipoproteins A1, B, and other prognostic biochemical cardiovascular risk factors in patients with beta-thalassemia major.

Khodayar Ghorban1, Mehrnoosh Shanaki2, Naser Mobarra1,3,4, Mehdi Azad5, Jahanbakhsh Asadi3, Reza Pakzad6, Hassan Ehteram7.   

Abstract

OBJECTIVES: The occurrence of cardiac iron deposition is one of the late effect of iron over load which causes cardiovascular disease (CVD) in patients who are affected by beta-thalassemia major. Evaluation of some cardiovascular risk factors plays a crucial role in prediction and prevention of CVD. SUBJECTS AND METHODS: This study consisted of 70 young adult subjects with beta-thalassemia major (beta-TM) (aged <30 years) and 71 age- and sex-matched healthy subjects as control group in the range of 20-30 years. Hematological and biochemical laboratory parameters including apolipoprotein (Apo)A1 and ApoB, oxidative stress biomarker pro-oxidant-antioxidant balance (PAB), homocysteine, serum high-sensitivity C-reactive protein (hs-CRP), and lipid profile were evaluated.
RESULTS: ApoA1, ApoB, lipid profiles, and homocysteine were significantly decreased in patients group (P < 0.001); however, very low-density lipoprotein and also mean corpuscular hemoglobin concentration (P > 0.05) were different. Some elements included ferritin (P < 0.001), PAB (P < 0.001), and ApoB/apoA1 ratio (P < 0.05) statistically increased in patients, whereas hs-CRP (P > 0.05) was not significantly different in study groups. Exception of high-density lipoprotein (P > 0.05), other lipid profiles, and apoB had a negative meaningful correlation with PAB (P < 0.05). Likewise, apoA1, apoB, apoB/A1 ratio with apoB and homocysteine showed a strong correlation (P < 0.05). We did not find a slight correlation between apoB/A1 ratio in the company of oxidative stress marker PAB (r = -0.366; P = 0.086). We found a statistical correlation between apoB/A1 and homocysteine (P < 0.05). DISCUSSION: Higher level of some risk factors like PAB values, apoB/A1 ratio concentration, and lipid profiles is able to involve in the prognostic pathological consequences in patients with beta-thalassemia major. Even so, they contribute toward the gradual development of CVD.

Entities:  

Keywords:  Apolipoprotein; Beta-thalassemia major; Cardiovascular disease; Oxidative stress

Mesh:

Substances:

Year:  2015        PMID: 25913481     DOI: 10.1179/1607845415Y.0000000016

Source DB:  PubMed          Journal:  Hematology        ISSN: 1024-5332            Impact factor:   2.269


  4 in total

1.  Comparative Proteome-Wide Analysis of Bone Marrow Microenvironment of β-Thalassemia/Hemoglobin E.

Authors:  Saranyoo Ponnikorn; Rungrawee Mongkolrob; Suwit Klongthalay; Sittiruk Roytrakul; Kitima Srisanga; Sumalee Tungpradabkul; Suradej Hongeng
Journal:  Proteomes       Date:  2019-02-23

2.  Methylation and Expression Status of The CpG-Island of SMG1 Promoter in Acute Myeloid Leukemia: A Follow-Up Study in Patients.

Authors:  Neda Karami; Mohammad Hossein Ahmadi; Saeed Mohammadi; Amirhosein Maali; Ahad Alizadeh; S Haghayegh Pishkhan Dibazar; Mehdi Azad
Journal:  Cell J       Date:  2022-04-27       Impact factor: 3.128

3.  The Gene Expression Profile and DNA Methylation Pattern of CDH1 and DNMT1 Genes in Acute Promyelocytic Leukemia (APL).

Authors:  Sanaz Zebardast; Mehdi Sahmani; Saeed Mohammadi; Farshad Foroughi; Ali Dehghani Fard; Zahra Mohammadi; Sahar Khojastepour; Mehdi Azad
Journal:  Rep Biochem Mol Biol       Date:  2020-01

Review 4.  A Review on Iron Chelators in Treatment of Iron Overload Syndromes.

Authors:  Naser Mobarra; Mehrnoosh Shanaki; Hassan Ehteram; Hajar Nasiri; Mehdi Sahmani; Mohsen Saeidi; Mehdi Goudarzi; Hoda Pourkarim; Mehdi Azad
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2016-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.